Marketing-authorisation holder · Italy
JANSSEN CILAG SpA
58 medicines in 3 countries, as authorisation holder and manufacturer.
Loading your page…
Loading your page…
Marketing-authorisation holder · Italy
58 medicines in 3 countries, as authorisation holder and manufacturer.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 58
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| DUROGESICCerotto transdermico | Fentanyl | Italy | Authorised | |
| EPREXSoluzione iniettabile in siringa pre-riempita | Epoetin alfa | Italy | Authorised | |
| PARIETCompressa gastroresistente | Rabeprazole | Italy | Authorised | |
| RISPERDALCompressa rivestita con film | Risperidone | Italy | Authorised | |
| SPORANOXCapsula rigida | Itraconazole | Italy | Authorised | |
| TOPAMAXCompressa rivestita con film | Topiramate | Italy | Authorised | |
| VERMOXCompressa | Mebendazole | Italy | Authorised | |
| BALVERSA | Erdafitinib | Saudi Arabia | Authorised | |
| CILEST TAB | Ethinyl estradiol, Norgestimate | Saudi Arabia | Authorised | |
| CILOPRINE CUM ANAESTHETICO EAR DROP SOLN | Acediasulphone, Cinchocaine, Oxymethurea | Saudi Arabia | Authorised | |
| DARZALEX 100 mg per 5 ml | Daratumumab | Saudi Arabia | Authorised | |
| Darzalex 1800 mg per 15 ml | Daratumumab | Saudi Arabia | Authorised | |
| DARZALEX 400 mg per 20 ml | Daratumumab | Saudi Arabia | Authorised | |
| EPREX 1000 U-0.5ML PREFILLED SYRING | Epoetin alfa | Saudi Arabia | Authorised | |
| EPREX 10000 U -ML PREFILLED SYRING | Epoetin alfa | Saudi Arabia | Authorised | |
| EPREX 2000 U-0.5ML PREFILLED SYRING | Epoetin alfa | Saudi Arabia | Authorised | |
| EPREX 3000IU-0.3ML PREFILLED SYRINGE | Epoetin alfa | Saudi Arabia | Authorised | |
| EPREX 40000 IU\ML PRE-FILLED SYRINGE | Epoetin alfa | Saudi Arabia | Authorised | |
| EPREX 40000IU\ML | Epoetin alfa | Saudi Arabia | Authorised | |
| EPREX 4000IU-0.4ML PROFILLED SYRING | Epoetin alfa | Saudi Arabia | Authorised | |
| EPREX NEW STABILIZER 4000IU-ML VIAL | Epoetin alfa | Saudi Arabia | Authorised | |
| IMBRUVICA | Ibrutinib | Saudi Arabia | Authorised | |
| Imodium Plus Caplets | Dimethicone, Loperamide | Saudi Arabia | Authorised | |
| INCIVO 375MG FILM COATED TABLET | Telaprevir | Saudi Arabia | Authorised | |
| INTELENCE 100 MG TABLETS | Etravirine | Saudi Arabia | Authorised |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Saudi Arabia | 47 | 47 | 0 | CompaniesAll medicines |
| Italy | 7 | 7 | 0 | CompaniesAll medicines |
| Romania | 4 | 0 | 4 | CompaniesAll medicines |
Also in the registers of Brazil, Croatia, Serbia, Singapore, Spain
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/OFFICINE_API_GIUGNO_2025.csv; HTTP Last-Modified Tue, 08 Jul 2025 11:28:20 GMT; acquired 2026-10-13T17:21:05.497592+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/officine_autorizzate_medicinali_30.06.2026.csv; HTTP Last-Modified Wed, 01 Jul 2026 09:37:30 GMT; acquired 2026-10-13T17:21:05.166252+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Ministero della Salute, Italy; https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; original CSV snapshot 15 October 2026, acquired 2026-10-15T13:26:43.659718+00:00; adapted factual fields under IODL2. Coordinates: © OpenStreetMap contributors, separate rights gate.
Report an error or request removalCorrections from the company itself are welcome.
Licence: Italian Open Data Licence v2.0, exact dataset-catalog assignment; coordinate fields separately attributed to OpenStreetMap
Ministero della Salute, Distributori di farmaci, source file13Oct2026. https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; IODL2.0 https://www.dati.gov.it/content/italian-open-data-license-v20. Original URLs/locators and retrieval timestamps; selected/normalized by Prognia; no government endorsement.
Licence: Italian Open Data Licence
Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence: Serbian Open Data Licence (sodl)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
Other companies in the same group.
Ranked by their number of medicines.